Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicology ; 258(2-3): 131-8, 2009 Apr 28.
Article in English | MEDLINE | ID: mdl-19428932

ABSTRACT

Male F-344 rats were administered corn oil (vehicle control), d-limonene (positive control, 300mg/kg), or MIBK (1000mg/kg) and female F-344 rats corn oil (vehicle control) or MIBK for 10 consecutive days by oral gavage. Approximately 24h after the final dose the kidneys were excised and the left kidney prepared and evaluated for histological changes including protein (hyaline) droplet accumulation, immunohistochemical staining for alpha2u-globulin (alpha2u), and proliferating cell nuclear antigen (PCNA) to quantitate renal cell proliferation. The right kidney was prepared for quantitation of total protein and alpha2u using an ELISA. MIBK elicited an increase in protein droplets, accumulation of alpha2u, and renal cell proliferation in male, but not female rats, responses characteristic of alpha2u-mediated nephropathy. MIBK produced identical histopathological changes in the male rat kidney when compared to d-limonene, an acknowledged inducer of alpha2u-nephropathy except that the grade of severity tended to be slightly lower with MIBK. MIBK did not induce any effects in female rats. Therefore, renal histopathology, along with the other measures of alpha2u accumulation, provides additional weight of evidence to support the inclusion of MIBK in the category of chemicals exerting renal effects through a alpha2u-nephropathy-mediated mode-of-action.


Subject(s)
Alpha-Globulins/metabolism , Kidney Diseases/chemically induced , Methyl n-Butyl Ketone/pharmacology , Administration, Oral , Animals , Cell Proliferation/drug effects , Female , Immunohistochemistry , Kidney Diseases/metabolism , Kidney Diseases/pathology , Male , Methyl n-Butyl Ketone/administration & dosage , Organ Size/drug effects , Proliferating Cell Nuclear Antigen/metabolism , Rats , Rats, Inbred F344
2.
Food Chem Toxicol ; 34(4): 393-405, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8641666

ABSTRACT

Chlorpyrifos (CPF), a widely used organophosphate insecticide, was screened for neurotoxic effects in Fischer 344 rats using United States Environmental Protection Agency 1991 guidelines for single-dose and 13-wk repeated dose studies. The studies emphasized a functional observational battery (which included grip performance and hindlimb splay tests), automated motor activity testing and comprehensive neurohistopathology of perfused tissues. Doses of up to 100 mg/kg body weight in corn oil by gavage in the single-dose study and up to 15 mg/kg body weight/day in diet for 13 wk in the repeated dose study were administered. It is known that CPF and other phosphorothionates can be activated to the oxon in local (extrahepatic) tissues. Local activation could possibly cause different effects in different tissues with cholinergic innervation, and thereby create syndromes unique to each phosphorothionate according to their structure. Consequently, the conduct of CPF neurotoxicity screening studies by contemporary guidelines offered opportunity to characterize the CPF over-exposure syndrome in rats. Single-dose high levels of oral exposure to CPF caused a range of clinical signs characteristic of cholinergic overstimulation. Although there was no clinical evidence of wide differences in sensitivity of one cholinergic response versus another, motor dysfunction (incoordination etc.) was more prominent than other signs, for example soiling. Effects were much more apparent in females and regressed over several days. Effects were minimal in the 13-wk study, and there was no evidence of accumulation of toxicity during the 13 wk of daily dietary exposure. Motor activity was decreased at the high dose in males and females at wk 4, but was not significantly different from controls in subsequent weeks. The 'normalization' of motor activity later in the study was interpreted as tolerance to repeated administration of CPF. Comprehensive neuropathological examination revealed no treatment-related lesions in either study.


Subject(s)
Behavior, Animal/drug effects , Chlorpyrifos/administration & dosage , Chlorpyrifos/toxicity , Administration, Oral , Animals , Body Weight/drug effects , Central Nervous System/drug effects , Central Nervous System/pathology , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Evaluation, Preclinical , Eliminative Behavior, Animal/drug effects , Female , Hindlimb/physiology , Intubation, Gastrointestinal , Male , Motor Activity/drug effects , Rats , Rats, Inbred F344
3.
Fundam Appl Toxicol ; 28(1): 18-26, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8566479

ABSTRACT

1,2-Dichloropropane (PDC) was evaluated for its potential to cause embryonal/fetal toxicity and teratogenicity in pregnant rats and rabbits. PDC was administered via oral gavage at dose levels of 0, 10, 30, or 125 mg/kg/day on Days 6 through 15 of gestation (rats) or 0, 15, 50, or 150 mg/kg/day on gestation Days 7 through 19 (rabbits). Fetuses were examined on Gestation Day 20 (rats) or Day 28 (rabbits). Maternal toxicity was observed in both rats and rabbits at the high dose levels. Rats given 125 mg/kg/day of PDC showed clinical signs of toxicity and decreased body weight and body weight gain. Rabbits given 150 mg/kg/day PDC showed changes in hematologic parameters and decreased body weight gain. Although maternal toxicity was apparent, no indication of teratogenicity was observed in rat or rabbit fetuses at any dose level. Significant increases in the incidence of delayed ossification of skull bones, considered secondary to decreased maternal body weight gain, were observed in rats given 125 mg/kg/day and in rabbits given 150 mg/kg/day. No maternal or developmental effects were observed in rats given 10 or 30 mg/kg/day or in rabbits given 15 or 50 mg/kg/day of PDC. Based on the results of these studies the maternal and developmental NOELs in rats and rabbits were 30 and 50 mg/kg/day, respectively.


Subject(s)
Propane/analogs & derivatives , Solvents/toxicity , Teratogens/toxicity , Abnormalities, Drug-Induced/pathology , Animals , Blood Cell Count/drug effects , Body Weight/drug effects , Eating/drug effects , Embryo Implantation/drug effects , Female , Fetal Movement/drug effects , Fetal Resorption/chemically induced , Fetus/pathology , Intubation, Gastrointestinal , Male , Pregnancy , Propane/administration & dosage , Propane/toxicity , Rabbits , Rats , Rats, Sprague-Dawley , Solvents/administration & dosage , Species Specificity , Weight Gain/drug effects
4.
Fundam Appl Toxicol ; 11(3): 464-71, 1988 Oct.
Article in English | MEDLINE | ID: mdl-3220217

ABSTRACT

Pregnant Fischer 344 rats and New Zealand White rabbits were orally administered 0, 5, 15, or 50 mg nitrapyrin/kg/day on Gestation Days 6 through 15 (rats) or 0, 3, 10, or 30 mg/kg/day on Gestation Days 6 through 18 (rabbits). In rats, 50 mg/kg/day produced slight histopathologic changes in the livers of pregnant females. Fetal examination revealed no evidence of fetotoxicity or teratogenicity among rats at dose levels up to 50 mg/kg/day. Among rabbits, a significant depression in maternal weight gain and increased absolute and relative liver weights were observed at 30 mg/kg/day. An increased incidence of crooked hyoid bone among fetal rabbits in the 30 mg/kg/day dose group was considered indicative of fetotoxicity but not teratogenicity. Thus, administration of nitrapyrin was not teratogenic at dose levels up to 50 mg/kg/day in rats and 30 mg/kg/day in rabbits.


Subject(s)
Picolines/toxicity , Teratogens , Administration, Oral , Animals , Body Weight/drug effects , Female , Fetus/drug effects , Gestational Age , Liver/drug effects , Male , Organ Size/drug effects , Pregnancy , Rabbits , Rats , Rats, Inbred F344 , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...